Science 25 May 1990: Vol. 248. no. 4958, pp. 1019 - 1023 DOI: 10.1126/science.2160731

Prev | Table of Contents | Next

Articles

Late Signals from CD27 Prevent Fas-Dependent Apoptosis of Primary CD8+ T Cells.

D. V. Dolfi, A. C. Boesteanu, C. Petrovas, D. Xia, E. A. Butz, and P. D. Katsikis (2008)
J. Immunol. 180, 2912-2921
 |  Abstract »  |  Full Text »  |  PDF »

Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.

J Adriaansen, M Khoury, C J de Cortie, F J Fallaux, P Bigey, D Scherman, D J Gould, Y Chernajovsky, F Apparailly, C Jorgensen, et al. (2007)
Ann Rheum Dis 66, 1143-1150
 |  Abstract »  |  Full Text »  |  PDF »

Identification of pH-Regulated Antigen 1 Released from Candida albicans as the Major Ligand for Leukocyte Integrin {alpha}Mbeta2.

D. A. Soloviev, W. A. Fonzi, R. Sentandreu, E. Pluskota, C. B. Forsyth, S. Yadav, and E. F. Plow (2007)
J. Immunol. 178, 2038-2046
 |  Abstract »  |  Full Text »  |  PDF »

Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of {delta}-PKC and ERK1/2.

L. E. Kilpatrick, S. Sun, D. Mackie, F. Baik, H. Li, and H. M. Korchak (2006)
J. Leukoc. Biol. 80, 1512-1521
 |  Abstract »  |  Full Text »  |  PDF »

Enhanced Fc-Dependent Cellular Cytotoxicity of Fc Fusion Proteins Derived from TNF Receptor II and LFA-3 by Fucose Removal from Asn-Linked Oligosaccharides.

E. Shoji-Hosaka, Y. Kobayashi, M. Wakitani, K. Uchida, R. Niwa, K. Nakamura, and K. Shitara (2006)
J. Biochem. 140, 777-783
 |  Abstract »  |  Full Text »  |  PDF »

Differential Functions of Tumor Necrosis Factor Receptor 1 and 2 Signaling in Ischemia-Mediated Arteriogenesis and Angiogenesis.

D. Luo, Y. Luo, Y. He, H. Zhang, R. Zhang, X. Li, W. L. Dobrucki, A. J. Sinusas, W. C. Sessa, and W. Min (2006)
Am. J. Pathol. 169, 1886-1898
 |  Abstract »  |  Full Text »  |  PDF »

Intestinal Intraepithelial Lymphocytes Sustain the Epithelial Barrier Function against Eimeria vermiformis Infection.

K. Inagaki-Ohara, F. N. Dewi, H. Hisaeda, A. L. Smith, F. Jimi, M. Miyahira, A. S. F. Abdel-Aleem, Y. Horii, and Y. Nawa (2006)
Infect. Immun. 74, 5292-5301
 |  Abstract »  |  Full Text »  |  PDF »

Protein Kinase C{epsilon} Activates Protein Kinase B/Akt via DNA-PK to Protect against Tumor Necrosis Factor-{alpha}-induced Cell Death.

D. Lu, J. Huang, and A. Basu (2006)
J. Biol. Chem. 281, 22799-22807
 |  Abstract »  |  Full Text »  |  PDF »

B Cell Maturation Antigen, the Receptor for a Proliferation-Inducing Ligand and B Cell-Activating Factor of the TNF Family, Induces Antigen Presentation in B Cells.

M. Yang, H. Hase, D. Legarda-Addison, L. Varughese, B. Seed, and A. T. Ting (2005)
J. Immunol. 175, 2814-2824
 |  Abstract »  |  Full Text »  |  PDF »

Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch.

C. A. Buckley, F. N. Rouhani, M. Kaler, B. Adamik, F. I. Hawari, and S. J. Levine (2005)
Am J Physiol Lung Cell Mol Physiol 288, L1132-L1138
 |  Abstract »  |  Full Text »  |  PDF »

Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum.

M Ostensen, F Forger, J L Nelson, A Schuhmacher, G Hebisch, and P M Villiger (2005)
Ann Rheum Dis 64, 839-844
 |  Abstract »  |  Full Text »  |  PDF »

Mechanisms of Soluble Cytokine Receptor Generation.

S. J. Levine (2004)
J. Immunol. 173, 5343-5348
 |  Abstract »  |  Full Text »  |  PDF »

Osteoporosis, Mineral Metabolism, and Serum Soluble Tumor Necrosis Factor Receptor p55 in Viral Cirrhosis.

J. L. Gonzalez-Calvin, F. Gallego-Rojo, R. Fernandez-Perez, F. Casado-Caballero, E. Ruiz-Escolano, and E. G. Olivares (2004)
J. Clin. Endocrinol. Metab. 89, 4325-4330
 |  Abstract »  |  Full Text »  |  PDF »

Serologic Assessment of Type 1 and Type 2 Immunity in Healthy Japanese Adults.

B. M. Birmann, N. Mueller, A. Okayama, C.-C. Hsieh, N. Tachibana, H. Tsubouchi, E. T. Lennette, D. Harn, and S. Stuver (2004)
Cancer Epidemiol. Biomarkers Prev. 13, 1385-1391
 |  Abstract »  |  Full Text »  |  PDF »

Estrogen Regulates Expression of Tumor Necrosis Factor Receptors in Breast Adipose Fibroblasts.

S. Deb, S. Amin, A. G. Imir, M. B. Yilmaz, T. Suzuki, H. Sasano, and S. E. Bulun (2004)
J. Clin. Endocrinol. Metab. 89, 4018-4024
 |  Abstract »  |  Full Text »  |  PDF »

TNF Activates Syk Protein Tyrosine Kinase Leading to TNF-Induced MAPK Activation, NF-{kappa}B Activation, and Apoptosis.

Y. Takada and B. B. Aggarwal (2004)
J. Immunol. 173, 1066-1077
 |  Abstract »  |  Full Text »  |  PDF »

New Drugs for Rheumatoid Arthritis.

N. J. Olsen and C. M. Stein (2004)
N. Engl. J. Med. 350, 2167-2179
 |  Full Text »  |  PDF »

Tumor necrosis factor activates CRE-binding protein through a p38 MAPK/MSK1 signaling pathway in endothelial cells.

J. A. Gustin, R. Pincheira, L. D. Mayo, O. N. Ozes, K. M. Kessler, M. R. Baerwald, C. K. Korgaonkar, and D. B. Donner (2004)
Am J Physiol Cell Physiol 286, C547-C555
 |  Abstract »  |  Full Text »  |  PDF »

Coupling Tumor Necrosis Factor-{alpha} with {alpha}V Integrin Ligands Improves Its Antineoplastic Activity.

F. Curnis, A. Gasparri, A. Sacchi, R. Longhi, and A. Corti (2004)
Cancer Res. 64, 565-571
 |  Abstract »  |  Full Text »  |  PDF »

A secreted high-affinity inhibitor of human TNF from Tanapox virus.

C. R. Brunetti, M. Paulose-Murphy, R. Singh, J. Qin, J. W. Barrett, A. Tardivel, P. Schneider, K. Essani, and G. McFadden (2003)
PNAS 100, 4831-4836
 |  Abstract »  |  Full Text »  |  PDF »

Resistance of Human Ovarian Cancer Cells to Tumor Necrosis Factor {alpha} Is a Consequence of Nuclear Factor {kappa}B-Mediated Induction of Fas-Associated Death Domain-Like Interleukin-1{beta}-Converting Enzyme-Like Inhibitory Protein.

C. W. Xiao, X. Yan, Y. Li, S. A. G. Reddy, and B. K. Tsang (2003)
Endocrinology 144, 623-630
 |  Abstract »  |  Full Text »  |  PDF »

Differential Expression of LIGHT and Its Receptors in Human Placental Villi and Amniochorion Membranes.

R. M. Gill, J. Ni, and J. S. Hunt (2002)
Am. J. Pathol. 161, 2011-2017
 |  Abstract »  |  Full Text »  |  PDF »

Involvement of CD40-CD40L signaling in postischemic lung injury.

T. M. Moore, W. B. Shirah, P. L. Khimenko, P. Paisley, R. N. Lausch, and A. E. Taylor (2002)
Am J Physiol Lung Cell Mol Physiol 283, L1255-L1262
 |  Abstract »  |  Full Text »  |  PDF »

Etk/Bmx as a Tumor Necrosis Factor Receptor Type 2-Specific Kinase: Role in Endothelial Cell Migration and Angiogenesis.

S. Pan, P. An, R. Zhang, X. He, G. Yin, and W. Min (2002)
Mol. Cell. Biol. 22, 7512-7523
 |  Abstract »  |  Full Text »  |  PDF »

The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model.

J. A. Symons, E. Adams, D. C. Tscharke, P. C. Reading, H. Waldmann, and G. L. Smith (2002)
J. Gen. Virol. 83, 2833-2844
 |  Abstract »  |  Full Text »  |  PDF »

Tumor necrosis factor-alpha inhibits renin gene expression.

V. Todorov, M. Muller, F. Schweda, and A. Kurtz (2002)
Am J Physiol Regulatory Integrative Comp Physiol 283, R1046-R1051
 |  Abstract »  |  Full Text »  |  PDF »

Requirement for the p75 TNF-{alpha} Receptor 2 in the Regulation of Airway Hyperresponsiveness by {gamma}{delta} T Cells.

A. Kanehiro, M. Lahn, M. J. Makela, A. Dakhama, A. Joetham, Y.-H. Rha, W. Born, and E. W. Gelfand (2002)
J. Immunol. 169, 4190-4197
 |  Abstract »  |  Full Text »  |  PDF »

Lipopolysaccharide Induces Overexpression of MUC2 and MUC5AC in Cultured Biliary Epithelial Cells : Possible Key Phenomenon of Hepatolithiasis.

Y. Zen, K. Harada, M. Sasaki, K. Tsuneyama, K. Katayanagi, Y. Yamamoto, and Y. Nakanuma (2002)
Am. J. Pathol. 161, 1475-1484
 |  Abstract »  |  Full Text »  |  PDF »

X-linked Inhibitor of Apoptosis (XIAP) Blocks Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis of Prostate Cancer Cells in the Presence of Mitochondrial Activation: Sensitization by Overexpression of Second Mitochondria-derived Activator of Caspase/Direct IAP-binding Protein with Low pI (Smac/DIABLO).

C.-P. Ng and B. Bonavida (2002)
Mol. Cancer Ther. 1, 1051-1058
 |  Abstract »  |  Full Text »  |  PDF »

Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue.

J. F. Panus, C. A. Smith, C. A. Ray, T. D. Smith, D. D. Patel, and D. J. Pickup (2002)
PNAS 99, 8348-8353
 |  Abstract »  |  Full Text »  |  PDF »

The Human Papillomavirus 16 E6 Protein Binds to Tumor Necrosis Factor (TNF) R1 and Protects Cells from TNF-induced Apoptosis.

M. Filippova, H. Song, J. L. Connolly, T. S. Dermody, and P. J. Duerksen-Hughes (2002)
J. Biol. Chem. 277, 21730-21739
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Biology of Thermoregulation: Invited Review: Cytokine regulation of fever: studies using gene knockout mice.

L. R. Leon (2002)
J Appl Physiol 92, 2648-2655
 |  Abstract »  |  Full Text »  |  PDF »

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists.

B. Scallon, A. Cai, N. Solowski, A. Rosenberg, X.-Y. Song, D. Shealy, and C. Wagner (2002)
J. Pharmacol. Exp. Ther. 301, 418-426
 |  Abstract »  |  Full Text »  |  PDF »

Tumor Necrosis Factor {alpha} (TNF-{alpha}) Activates Jak1/Stat3-Stat5B Signaling through TNFR-1 in Human B Cells.

S. Miscia, M. Marchisio, A. Grilli, V. Di Valerio, L. Centurione, G. Sabatino, F. Garaci, G. Zauli, E. Bonvini, and A. Di Baldassarre (2002)
Cell Growth Differ. 13, 13-18
 |  Abstract »  |  Full Text »  |  PDF »

Soluble CD137 (4-1BB) Ligand Is Released Following Leukocyte Activation and Is Found in Sera of Patients with Hematological Malignancies.

H. R. Salih, H. M. Schmetzer, C. Burke, G. C. Starling, R. Dunn, R. Pelka-Fleischer, V. Nuessler, and P. A. Kiener (2001)
J. Immunol. 167, 4059-4066
 |  Abstract »  |  Full Text »  |  PDF »

TNF-{alpha} induces protein synthesis through PI3-kinase-Akt/PKB pathway in cardiac myocytes.

E. Hiraoka, S. Kawashima, T. Takahashi, Y. Rikitake, T. Kitamura, W. Ogawa, and M. Yokoyama (2001)
Am J Physiol Heart Circ Physiol 280, H1861-H1868
 |  Abstract »  |  Full Text »  |  PDF »

Nuclear Factor-{{kappa}}B-Mediated X-Linked Inhibitor of Apoptosis Protein Expression Prevents Rat Granulosa Cells from Tumor Necrosis Factor {{alpha}}-Induced Apoptosis.

C. W. Xiao, K. Ash, and B. K. Tsang (2001)
Endocrinology 142, 557-563
 |  Abstract »  |  Full Text »  |  PDF »

Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: A Novel Syndrome With Cutaneous Manifestations.

J. R. Toro, I. Aksentijevich, K. Hull, J. Dean, and D. L. Kastner (2000)
Arch Dermatol 136, 1487-1494
 |  Abstract »  |  Full Text »  |  PDF »

Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappa B.

B. B Aggarwal (2000)
Ann Rheum Dis 59, i6-16
 |  Abstract »  |  Full Text »  |  PDF »

Reciprocal Expression of the TNF Family Receptor Herpes Virus Entry Mediator and Its Ligand LIGHT on Activated T Cells: LIGHT Down-Regulates Its Own Receptor.

Y. Morel, J.-M. Schiano de Colella, J. Harrop, K. C. Deen, S. D. Holmes, T. A. Wattam, S. S. Khandekar, A. Truneh, R. W. Sweet, J.-A. Gastaut, et al. (2000)
J. Immunol. 165, 4397-4404
 |  Abstract »  |  Full Text »  |  PDF »

Constitutive Expression of Functional 4-1BB (CD137) Ligand on Carcinoma Cells.

H. R. Salih, S. G. Kosowski, V. F. Haluska, G. C. Starling, D. T. Loo, F. Lee, A. A. Aruffo, P. A. Trail, and P. A. Kiener (2000)
J. Immunol. 165, 2903-2910
 |  Abstract »  |  Full Text »  |  PDF »

A Role for CD40-CD40 Ligand Interactions in the Generation of Type 1 Cytokine Responses in Human Leprosy.

P. S. Yamauchi, J. R. Bleharski, K. Uyemura, J. Kim, P. A. Sieling, A. Miller, H. Brightbill, K. Schlienger, T. H. Rea, and R. L. Modlin (2000)
J. Immunol. 165, 1506-1512
 |  Abstract »  |  Full Text »  |  PDF »

Cytokine Blockade as a New Strategy to Treat Rheumatoid Arthritis: Inhibition of Tumor Necrosis Factor.

D. A. Fox (2000)
Arch Intern Med 160, 437-444
 |  Abstract »  |  Full Text »  |  PDF »

Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance in Adipocytes.

C. Qi and P. H. Pekala (2000)
Experimental Biology and Medicine 223, 128-135
 |  Abstract »  |  Full Text »

CD30-CD30 Ligand Interaction in Primary Cutaneous CD30+ T-Cell Lymphomas: A Clue to the Pathophysiology of Clinical Regression.

M. Mori, C. Manuelli, N. Pimpinelli, C. Mavilia, E. Maggi, M. Santucci, B. Bianchi, P. Cappugi, B. Giannotti, and M.E. Kadin (1999)
Blood 94, 3077-3083
 |  Abstract »  |  Full Text »  |  PDF »

Activation of Jun N-terminal Kinase/Stress-activated Protein Kinase Pathway by Tumor Necrosis Factor alpha Leads to Intercellular Adhesion Molecule-1 Expression.

P. De Cesaris, D. Starace, G. Starace, A. Filippini, M. Stefanini, and E. Ziparo (1999)
J. Biol. Chem. 274, 28978-28982
 |  Abstract »  |  Full Text »  |  PDF »

How Specific Should Immunological Memory Be?.

J. A. M. Borghans, A. J. Noest, and R. J. De Boer (1999)
J. Immunol. 163, 569-575
 |  Abstract »  |  Full Text »  |  PDF »

Signal Transduction by Tumor Necrosis Factor: The Parker B. Francis Lectureship.

D. V. Goeddel (1999)
Chest 116, 69S-73S
 |  Full Text »

A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis.

K.-Y. Yu, B. Kwon, J. Ni, Y. Zhai, R. Ebner, and B. S. Kwon (1999)
J. Biol. Chem. 274, 13733-13736
 |  Abstract »  |  Full Text »  |  PDF »

Tumor Necrosis Factor-alpha Mediates Both Apoptotic Cell Death and Cell Proliferation in a Human Hematopoietic Cell Line Dependent on Mitotic Activity and Receptor Subtype Expression.

G. T. Baxter, R. C. Kuo, O. J. Jupp, P. Vandenabeele, and D. J. MacEwan (1999)
J. Biol. Chem. 274, 9539-9547
 |  Abstract »  |  Full Text »  |  PDF »

Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial.

L. W. Moreland, M. H. Schiff, S. W. Baumgartner, E. A. Tindall, R. M. Fleischmann, K. J. Bulpitt, A. L. Weaver, E. C. Keystone, D. E. Furst, P. J. Mease, et al. (1999)
Ann Intern Med 130, 478-486
 |  Abstract »  |  Full Text »  |  PDF »

Hydrogen Peroxide Enhances Shedding of Type I Soluble Tumor Necrosis Factor Receptor from Pulmonary Epithelial Cells.

T. Hino, H. Nakamura, S. Abe, H. Saito, M. Inage, K. Terashita, S. Kato, and H. Tomoike (1999)
Am. J. Respir. Cell Mol. Biol. 20, 122-128
 |  Abstract »  |  Full Text »

Review Article: Apoptosis in the Kidney.

M. A. Davis and D. H. Ryan (1998)
Toxicol Pathol 26, 810-825
 |  Abstract »  |  PDF »

NF-{kappa}B Activation in CD27 Signaling: Involvement of TNF Receptor-Associated Factors in Its Signaling and Identification of Functional Region of CD27.

H. Yamamoto, T. Kishimoto, and S. Minamoto (1998)
J. Immunol. 161, 4753-4759
 |  Abstract »  |  Full Text »  |  PDF »

Herpesvirus Entry Mediator Ligand (HVEM-L), a Novel Ligand for HVEM/TR2, Stimulates Proliferation of T Cells and Inhibits HT29 Cell Growth.

J. A. Harrop, P. C. McDonnell, M. Brigham-Burke, S. D. Lyn, J. Minton, K. B. Tan, K. Dede, J. Spampanato, C. Silverman, P. Hensley, et al. (1998)
J. Biol. Chem. 273, 27548-27556
 |  Abstract »  |  Full Text »  |  PDF »

Cooperative Signaling by Tumor Necrosis Factor Receptors CD120a (p55) and CD120b (p75) in the Expression of Nitric Oxide and Inducible Nitric Oxide Synthase by Mouse Macrophages.

D. W. H. Riches, E. D. Chan, E. A. Zahradka, B. W. Winston, L. K. Remigio, and F. R. Lake (1998)
J. Biol. Chem. 273, 22800-22806
 |  Abstract »  |  Full Text »  |  PDF »

Antibodies to TR2 (Herpesvirus Entry Mediator), a New Member of the TNF Receptor Superfamily, Block T Cell Proliferation, Expression of Activation Markers, and Production of Cytokines.

J. A. Harrop, M. Reddy, K. Dede, M. Brigham-Burke, S. Lyn, K. B. Tan, C. Silverman, C. Eichman, R. DiPrinzio, J. Spampanato, et al. (1998)
J. Immunol. 161, 1786-1794
 |  Abstract »  |  Full Text »  |  PDF »

TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption.

B. S. Kwon, S. Wang, N. Udagawa, V. Haridas, Z. H. Lee, K. K. Kim, K.-o. Oh, J. Greene, Y. Li, J. Su, et al. (1998)
FASEB J 12, 845-854
 |  Abstract »  |  Full Text »

Differential Expression of a Tumor Necrosis Factor Receptor-Related Transcript in Gestational Trophoblastic Diseases in Women.

C. I. Dumur, N. P. Koritschoner, A. Flury, G. Panzetta-Dutari, J. L. Bocco, and L. C. Patrito (1998)
Biol Reprod 59, 621-625
 |  Abstract »  |  Full Text »

Phosphorylation of FADD/MORT1 and Fas by Kinases That Associate with the Membrane-Proximal Cytoplasmic Domain of Fas.

N. J. Kennedy and R. C. Budd (1998)
J. Immunol. 160, 4881-4888
 |  Abstract »  |  Full Text »  |  PDF »

High CD30 Ligand Expression by Epithelial Cells and Hassal's Corpuscles in the Medulla of Human Thymus.

P. Romagnani, F. Annunziato, R. Manetti, C. Mavilia, L. Lasagni, C. Manuelli, G. B. Vannelli, V. Vanini, E. Maggi, C. Pupilli, et al. (1998)
Blood 91, 3323-3332
 |  Abstract »  |  Full Text »  |  PDF »

Serum Level of the Soluble Form of the CD30 Molecule Identifies Patients With Hodgkin's Disease at High Risk of Unfavorable Outcome.

G. Nadali, L. Tavecchia, E. Zanolin, V. Bonfante, S. Viviani, E. Camerini, P. Musto, N. Di Renzo, M. Carotenuto, M. Chilosi, et al. (1998)
Blood 91, 3011-3016
 |  Abstract »  |  Full Text »  |  PDF »

A third distinct tumor necrosis factor receptor of orthopoxviruses.

V. N. Loparev, J. M. Parsons, J. C. Knight, J. F. Panus, C. A. Ray, R. M. L. Buller, D. J. Pickup, and J. J. Esposito (1998)
PNAS 95, 3786-3791
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Jak/STAT Signaling by Activation of the Type 1 TNF Receptor.

D. Guo, J. D. Dunbar, C. H. Yang, L. M. Pfeffer, and D. B. Donner (1998)
J. Immunol. 160, 2742-2750
 |  Abstract »  |  Full Text »  |  PDF »

Mutation of Proline 211 Reduces Shedding of the Human p75 TNF Receptor.

C. Herman and Y. Chernajovsky (1998)
J. Immunol. 160, 2478-2487
 |  Abstract »  |  Full Text »  |  PDF »

Complex Formation Facilitates Endocytosis of the Varicella-Zoster Virus gE:gI Fc Receptor.

J. K. Olson and C. Grose (1998)
J. Virol. 72, 1542-1551
 |  Abstract »  |  Full Text »  |  PDF »

High Resolution Crystal Structure of a Human Tumor Necrosis Factor-alpha Mutant with Low Systemic Toxicity.

S.-S. Cha, J.-S. Kim, H.-S. Cho, N.-K. Shin, W. Jeong, H.-C. Shin, Y. J. Kim, J. H. Hahn, and B.-H. Oh (1998)
J. Biol. Chem. 273, 2153-2160
 |  Abstract »  |  Full Text »  |  PDF »

TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation.

J. J. Peschon, D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler (1998)
J. Immunol. 160, 943-952
 |  Abstract »  |  Full Text »  |  PDF »

Cytokine Profiles of Cells Extracted from Humans with Periodontal Diseases.

E. Gemmell and G.J. Seymour (1998)
Journal of Dental Research 77, 16-26
 |  Abstract »  |  PDF »

The Involvement of Novel Protein Kinase C Isozymes in Influencing Sensitivity of Breast Cancer MCF-7 Cells to Tumor Necrosis Factor-alpha.

A. Basu (1998)
Mol. Pharmacol. 53, 105-111
 |  Abstract »  |  Full Text »

Differential Activities of Secreted Lymphotoxin-{alpha}3 and Membrane Lymphotoxin-{alpha}1{beta}2 in Lymphotoxin-Induced Inflammation: Critical Role of TNF Receptor 1 Signaling.

R. Sacca, C. A. Cuff, W. Lesslauer, and N. H. Ruddle (1998)
J. Immunol. 160, 485-491
 |  Abstract »  |  Full Text »  |  PDF »

Interleukin-10 Upregulates Tumor Necrosis Factor Receptor Type-II (p75) Gene Expression in Endotoxin-Stimulated Human Monocytes.

H. L. Dickensheets, S. L. Freeman, M. F. Smith Jr, and R. P. Donnelly (1997)
Blood 90, 4162-4171
 |  Abstract »  |  Full Text »  |  PDF »

TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells.

B. R. Wong, J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F. S. Bartlett III, W. N. Frankel, et al. (1997)
J. Biol. Chem. 272, 25190-25194
 |  Abstract »  |  Full Text »  |  PDF »

The Lymphotoxin-alpha (LTalpha ) Subunit Is Essential for the Assembly, but Not for the Receptor Specificity, of the Membrane-anchored LTalpha 1beta 2 Heterotrimeric Ligand.

L. Williams-Abbott, B. N. Walter, T. C. Cheung, C. R. Goh, A. G. Porter, and C. F. Ware (1997)
J. Biol. Chem. 272, 19451-19456
 |  Abstract »  |  Full Text »  |  PDF »

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)-Fc Fusion Protein.

L. W. Moreland, S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann, A. L. Weaver, R. E. Ettlinger, S. Cohen, W. J. Koopman, K. Mohler, et al. (1997)
N. Engl. J. Med. 337, 141-147
 |  Abstract »  |  Full Text »  |  PDF »

A Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily with a Wide Tissue Distribution and Involvement in Lymphocyte Activation.

B. S. Kwon, K. B. Tan, J. Ni, K. K. Kim, Y.-J. Kim, S. Wang, R. Gentz, G.-L. Yu, J. Harrop, S. D. Lyn, et al. (1997)
J. Biol. Chem. 272, 14272-14276
 |  Abstract »  |  Full Text »  |  PDF »

Lymphotoxin-beta receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappa B.

T. L. VanArsdale, S. L. VanArsdale, W. R. Force, B. N. Walter, G. Mosialos, E. Kieff, J. C. Reed, and C. F. Ware (1997)
PNAS 94, 2460-2465
 |  Abstract »  |  Full Text »  |  PDF »

Affinity and Kinetics of the Interaction between Soluble Trimeric OX40 Ligand, a Member of the Tumor Necrosis Factor Superfamily, and Its Receptor OX40 on Activated T Cells.

A. Al-Shamkhani, S. Mallett, M. H. Brown, W. James, and A. N. Barclay (1997)
J. Biol. Chem. 272, 5275-5282
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of p75 Tumor Necrosis Factor Receptor by Antisense Oligonucleotides Increases Hypoxic Injury and beta -Amyloid Toxicity in Human Neuronal Cell Line.

Y. Shen, R. Li, and K. Shiosaki (1997)
J. Biol. Chem. 272, 3550-3553
 |  Abstract »  |  Full Text »  |  PDF »

The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex.

H.-B. Shu, M. Takeuchi, and D. V. Goeddel (1996)
PNAS 93, 13973-13978
 |  Abstract »  |  Full Text »  |  PDF »

Identification of TRAF6, a Novel Tumor Necrosis Factor Receptor-associated Factor Protein That Mediates Signaling from an Amino-terminal Domain of the CD40 Cytoplasmic Region.

T. Ishida, S.-i. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, et al. (1996)
J. Biol. Chem. 271, 28745-28748
 |  Abstract »  |  Full Text »  |  PDF »

Tumor Necrosis Factor Receptors (Tnfr) in Mouse Fibroblasts Deficient in Tnfr1 or Tnfr2 are Signaling Competent and Activate the Mitogen-activated Protein Kinase Pathway with Differential Kinetics.

A. Kalb, H. Bluethmann, M. W. Moore, and W. Lesslauer (1996)
J. Biol. Chem. 271, 28097-28104
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of Histidine Residues Essential for Receptor Binding and Activity of Nerve Growth Factor.

S. B. Woo and K. E. Neet (1996)
J. Biol. Chem. 271, 24433-24441
 |  Abstract »  |  Full Text »  |  PDF »

Human Tumor Necrosis Factor Receptor p75/80 (CD120b) Gene Structure and Promoter Characterization.

S. M. Santee and L. B. Owen-Schaub (1996)
J. Biol. Chem. 271, 21151-21159
 |  Abstract »  |  Full Text »  |  PDF »

Fibroblast Growth Factor-2 Suppression of Tumor Necrosis Factor alpha -Mediated Apoptosis Requires Ras and the Activation of Mitogen-activated Protein Kinase.

A. M. Gardner and G. L. Johnson (1996)
J. Biol. Chem. 271, 14560-14566
 |  Abstract »  |  Full Text »  |  PDF »

Interaction between the mRNA of the 55-kDa Tumor Necrosis Factor Receptor and Cellular Proteins. POSSIBLE INVOLVEMENT IN POST-TRANSCRIPTIONAL REGULATION OF RECEPTOR EXPRESSION.

R. Winzen, S. Kafert, B. P. H. A. Mylius-Spencker, K. Resch, and H. Holtmann (1996)
J. Biol. Chem. 271, 13461-13467
 |  Abstract »  |  Full Text »  |  PDF »

Cytokines and viral anti-immune genes.

C. Evans (1996)
Stem Cells 14, 177-184
 |  Abstract »

Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium.

G. Torre-Amione, S. Kapadia, J. Lee, R. D. Bies, R. Lebovitz, and D. L. Mann (1995)
Circulation 92, 1487-1493
 |  Abstract »  |  Full Text »

Epitopic Regions for Antibodies against Tumor Necrosis Factor alpha.

K. Yone, S. Bajard, N. Tsunekawa, and J. Suzuki (1995)
J. Biol. Chem. 270, 19509-19515
 |  Abstract »  |  Full Text »  |  PDF »

Cross-linking of the p55 Tumor Necrosis Factor Receptor Cytoplasmic Domain by a Dimeric Ligand Induces Nuclear Factor-[IMAGE]B and Mediates Cell Death.

D. Adam, D. Adam, and M. Krönke (1995)
J. Biol. Chem. 270, 17482-17487
 |  Abstract »  |  Full Text »  |  PDF »

Vaccinia Virus B18R Gene Encodes a Type I Interferon-binding Protein That Blocks Interferon [IMAGE] Transmembrane Signaling.

O. R. Colamonici, P. Domanski, S. M. Sweitzer, A. Larner, and R. M. L. Buller (1995)
J. Biol. Chem. 270, 15974-15978
 |  Abstract »  |  Full Text »  |  PDF »

Soluble tumor necrosis factor receptors are released independent of TNF in endotoxemia.

F. Otto, A. Seiz, C. Galanos, R. Mertelsmann, and R. Engelhardt (1995)
Innate Immunity 2, 85-89
 |  Abstract »  |  PDF »

Alteration of NH(2)-terminal Residues of Nerve Growth Factor Affects Activity and Trk Binding without Affecting Stability or Conformation.

S. B. Woo, D. E. Timm, and K. E. Neet (1995)
J. Biol. Chem. 270, 6278-6285
 |  Abstract »  |  Full Text »  |  PDF »

Identification of a Protein with Homology to hsp90 That Binds the Type 1 Tumor Necrosis Factor Receptor.

H. Y. Song, J. D. Dunbar, Y. X. Zhang, D. Guo, and D. B. Donner (1995)
J. Biol. Chem. 270, 3574-3581
 |  Abstract »  |  Full Text »  |  PDF »

Self-association of the ``Death Domains'' of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects.

M. P. Boldin, I. L. Mett, E. E. Varfolomeev, I. Chumakov, Y. Shemer-Avni, J. H. Camonis, and D. Wallach (1995)
J. Biol. Chem. 270, 387-391
 |  Abstract »  |  Full Text »  |  PDF »

Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor.

R. Dobrowsky, M. Werner, A. Castellino, M. Chao, and Y. Hannun (1994)
Science 265, 1596-1599
 |  Abstract »  |  PDF »

A lymphotoxin-beta-specific receptor.

P. Crowe, T. VanArsdale, B. Walter, C. Ware, C Hession, B Ehrenfels, J. Browning, W. Din, R. Goodwin, and C. Smith (1994)
Science 264, 707-710
 |  Abstract »  |  PDF »

Mapping the lectin-like activity of tumor necrosis factor.

R Lucas, S Magez, R De Leys, L Fransen, J. Scheerlinck, M Rampelberg, E Sablon, and P De Baetselier (1994)
Science 263, 814-817
 |  Abstract »  |  PDF »

An antiviral soluble form of the LDL receptor induced by interferon.

D. Fischer, N Tal, D Novick, S Barak, and M Rubinstein (1993)
Science 262, 250-253
 |  Abstract »  |  PDF »

To Advertise   |   Find Products